Literature DB >> 10884288

Sjögren-Larsson syndrome: accumulation of free fatty alcohols in cultured fibroblasts and plasma.

W B Rizzo1, D A Craft.   

Abstract

Sjögren-Larsson syndrome (SLS) is an inherited disorder associated with deficient oxidation of long-chain aliphatic alcohols. Previous studies have reported modest elevations in total (free + esterified) fatty alcohols in SLS, but free fatty alcohols have not been selectively measured, in part because of their low concentrations in most tissues and the presence of trace fatty alcohol contaminants in some solvents used for their analysis. We adapted methods to measure free fatty alcohols in cultured cells and plasma that minimize exogenous alcohol contamination. Fatty alcohols were analyzed as acetate derivatives, using capillary column gas chromatography. By this method, cultured skin fibroblasts from SLS patients were found to have 7- and 8-fold elevations in the mean content of hexadecanol (16:0-OH) and octadecanol (18:0-OH), respectively. The mean plasma 16:0-OH and 18:0-OH concentrations in SLS patients (n = 11) were 9- and 22-fold higher than in normal controls, respectively. In SLS fibroblasts, most of the fatty alcohol (59%) that accumulated was free rather than esterified alcohol, whereas free alcohol accounted for 23% of the total alcohol in normal cells. These results indicate that elevations in free fatty alcohols provide a sensitive marker for the enzymatic defect in SLS. The ability to measure free fatty alcohols in cultured cells and plasma should prove useful for investigations of normal fatty alcohol metabolism and the deranged metabolism in SLS.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10884288

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  24 in total

1.  An examination of pentafluorobenzoyl derivatization strategies for the analysis of fatty alcohols using gas chromatography/electron capture negative ion chemical ionization-mass spectrometry.

Authors:  John A Bowden; David A Ford
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2010-11-04       Impact factor: 3.205

2.  Disruption of the Sjögren-Larsson Syndrome Gene Aldh3a2 in Mice Increases Keratinocyte Growth and Retards Skin Barrier Recovery.

Authors:  Tatsuro Naganuma; Shuyu Takagi; Tsukasa Kanetake; Takuya Kitamura; Satoko Hattori; Tsuyoshi Miyakawa; Takayuki Sassa; Akio Kihara
Journal:  J Biol Chem       Date:  2016-04-06       Impact factor: 5.157

3.  Large contiguous gene deletions in Sjögren-Larsson syndrome.

Authors:  Holly Engelstad; Gael Carney; Dana S'aulis; Janae Rise; Warren G Sanger; M Katharine Rudd; Gabriele Richard; Christopher W Carr; Omar A Abdul-Rahman; William B Rizzo
Journal:  Mol Genet Metab       Date:  2011-05-30       Impact factor: 4.797

4.  Aldehyde dehydrogenase 3 converts farnesal into farnesoic acid in the corpora allata of mosquitoes.

Authors:  Crisalejandra Rivera-Perez; Marcela Nouzova; Mark E Clifton; Elena Martin Garcia; Elizabeth LeBlanc; Fernando G Noriega
Journal:  Insect Biochem Mol Biol       Date:  2013-04-29       Impact factor: 4.714

5.  Macular crystalline inclusions in Sjögren-Larsson syndrome are dynamic structures that undergo remodeling.

Authors:  Shaza N Al-Holou; Edward Siefker; Samiksha Fouzdar-Jain; Donny W Suh; William B Rizzo
Journal:  Ophthalmic Genet       Date:  2020-06-08       Impact factor: 1.803

Review 6.  Sjögren-Larsson syndrome: molecular genetics and biochemical pathogenesis of fatty aldehyde dehydrogenase deficiency.

Authors:  William B Rizzo
Journal:  Mol Genet Metab       Date:  2006-09-22       Impact factor: 4.797

7.  Chlorinated lipid species in activated human neutrophils: lipid metabolites of 2-chlorohexadecanal.

Authors:  Dhanalakshmi S Anbukumar; Laurie P Shornick; Carolyn J Albert; Melissa M Steward; Raphael A Zoeller; William L Neumann; David A Ford
Journal:  J Lipid Res       Date:  2009-12-17       Impact factor: 5.922

8.  MR imaging and proton MR spectroscopic studies in Sjögren-Larsson syndrome: characterization of the leukoencephalopathy.

Authors:  Michèl A A P Willemsen; Marinette Van Der Graaf; Marjo S Van Der Knaap; Arend Heerschap; Peter H M F Van Domburg; Fons J M Gabreëls; Jan J Rotteveel
Journal:  AJNR Am J Neuroradiol       Date:  2004-04       Impact factor: 3.825

Review 9.  Sjögren-Larsson syndrome in clinical practice.

Authors:  Joris Fuijkschot; Thomas Theelen; Marieke M B Seyger; Marinette van der Graaf; Imelda J M de Groot; Ron A Wevers; Ronald J A Wanders; Hans R Waterham; Michèl A A P Willemsen
Journal:  J Inherit Metab Dis       Date:  2012-07-26       Impact factor: 4.982

10.  Ichthyosis in Sjögren-Larsson syndrome reflects defective barrier function due to abnormal lamellar body structure and secretion.

Authors:  William B Rizzo; Dana S'Aulis; M Anitia Jennings; Debra A Crumrine; Mary L Williams; Peter M Elias
Journal:  Arch Dermatol Res       Date:  2010-01-05       Impact factor: 3.017

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.